ArticleOpen medicine (Warsaw, Poland)2026
Safety and effectiveness of nafamostat mesylate in continuous renal replacement therapy in patients with sepsis-associated acute kidney injury: a prospective randomized controlled trial.
Yu Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.